Lockdown 3.0: Pharma hubs take extra precaution to tame Covid-19 outbreak
Recently, while 26 workers at Cadila Pharmaceuticals facility in Ahmedabad tested positive for Covid-19, one person at Sun Pharma's Halol plant tested positive.08-05-2020
08-05-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed Compliance Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201504-05-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Ashok BhutaDesignation :- Any Other04-05-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 04, 2020 for Raksha Sudhir Valia04-05-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Shareholding for the Period Ended March 31, 2020
Sun Pharmaceutical Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here30-04-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed compliance certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201529-04-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed Certificate under Reg. 74(5) of SEBI (DP) Regulations, 201824-04-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed Certificate under Reg. 74(5) of SEBI (DP) Regulations, 201824-04-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed Certificate under Reg. 74(5) of SEBI (DP) Regulations, 201824-04-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 22, 2020 for Shanghvi Finance Pvt Ltd22-04-2020